About
JH-TIE

The Johns Hopkins Center for Translational ImmunoEngineering, JH-TIE, is a member of the National Centers for Biomedical Imaging and Bioengineering (NCBIB) network, which is supported by the National Institute of Biomedical Imaging and Bioengineering. Our goal is to interface with bioengineers, immunologists, material scientists, and biomedical researchers to develop tools, techniques, and protocols that are broadly relevant to immune and inflammatory diseases, engage in new collaborations, provide training for graduate and post-graduate investigators; and maximize the potential of immunoengineering and immune-based therapies. Learn more.

Research
Projects

Our rapidly increasing understanding of the power of immune effectors, combined with development of advanced genomic tools, has generated the new field of immunoengineering, with a promise to revolutionize treatments for infectious disease, autoimmune disorders, and cancer. However, application of these breakthroughs has been stymied by remaining knowledge gaps, inefficiencies, and operational barriers between immunologists, engineers, and other partners who could collaborate and innovate. JH-TIE’s vision is to control the powerful, yet sometimes competing, outcomes of immunity by developing advanced technologies to engineer, direct, and ultimately control immune responses. Learn more.

Collaborative
Partnerships

In addition to its scientific goals, a key aspect of JH-TIE is bringing together diverse disciplines, with their distinct tools, methods, and expertise, to advance immunology and its clinical applications. Our novel techniques continue to develop in response to the distinct needs of our collaborators. While the tools we develop are finely tuned to achieve specific results, they are also adjustable for different but related circumstances, JH-TIE’s collaborative projects drive our TR&D research programs and are a diverse set of collaborations spread across the US on both coasts, Ohio, and Indiana. Service project partners include both academic and biotech companies, such as NexImmune, Sanofi, and GSK. Learn more.

Training
Opportunities

Immunoengineering is a rapidly growing field that integrates two diverse, complex disciplines: engineering and immunology.  JH-TIE aims to break barriers between the fields by providing broad dissemination of immunoengineering principles, tools, and technical advances and facilitating collaborations between immunologists and engineers. With an integrated immunology-and-engineering approach, we can address a myriad of challenges and a wide variety of applications such as cancer immunotherapy and tissue engineering. Blurring the lines between immunology and engineering brings a unique synergy in medicine that our education, training, and dissemination goals aim to impact. Learn more.

Get in
Touch

Get in touch with the JH-TIE team for more information about our TR&D research projects, collaborative and service projects, tools, resources, publications, training initiatives, resources, media inquiries, to collaborate, and more. Learn more.